EccaTru™ is the commercial name of the active ingredient echinacoside titrated at 4% and purified from Echinacea Angustifolia.
Echinacoside is a secondary metabolite produced by the plant as a defensive compound against pathogens. Echinacoside is a natural caffeic acid glycoside consisting of a trisaccharide formed by two glucose molecules and one rhamnose moiety.
Clinical Studies on Echinacoside have proved beneficial effects on:
- fighting flu and flu-like infections
- modulating immunosuppressive conditions
- reducing risk for medical complications in upper respiratory infections
- modulating the erythropoietin production without affecting red blood cells count
VerbaTru™ is the commercial name of the active ingredient Verbascoside titrated at 10%, extracted and purified from Lippia Citriadora suspension cell culture.
Scientific literature attributes various biological properties to to Verbascoside including anti-hepatotoxic, antinflammatory, anti-nociceptive, antioxidant and antihemolytic effects.
Verbascoside also demonstrated relevant effects in the reduction of symptoms in chronic pathologies and conditions such as:
- Parkinson’s disease
- Alzheimer’s disease
- Estrogenic mediated diseases
- Allergy type 1
- Intestinal mucosytis
TeppaTru™ is the commercial name for the active ingredient Teupolioside titrated at 10% and 50% respectively, extracted and purified from Ajuga Reptans suspension cell culture.
Teupolioside has shown a wide range of activities and it generally acts as an anti-inflammatory molecule. Moreover, Teupolioside is able to modulate testosterone-related disorders, like juvenile acne, and for the prevention of hair loss in androgenic alopecia.
Specific in vitro and in vivo studies demonstrated that Teupolioside has beneficial effects also on other pathologic conditions such as:
- Benign prostatic hyperplasia (BPH)
- Crohn’s syndrome and other gastro-intestinal diseases
- Microvasculature diseases